Company news

PolyNovo Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Research project collaboration with Beta Cell Technologies

May 11, 2017

Additional Success US BTM use

February 26, 2017

First BTM patient in US

February 22, 2017

South Africa first order for BTM

February 16, 2017

First stock purchase

December 21, 2016

PolyNovos South Africa Market Entry

December 8, 2016

S&P DJ Indices Announces March Quarterly Review

November 7, 2016

US Market Entry-PolyNovo

October 2, 2016

Full Year Statutory Accounts and Appendix 4E

August 22, 2016

Financial result guidance

August 7, 2016

BTM use in Diabetes Islet Cell Transplantation Study

July 24, 2016

Additional BARDA Option Exercised Valued at US$2.4m

May 31, 2016

US Regulatory Update

March 30, 2016

NovoSkin awarded BioInnovationSA Grant

March 30, 2016

Feasibility Study Extended by 12 Months

March 30, 2016

CZD: Termination of Metabolic vend-in proposal

March 30, 2016

PolyNovo US Patent Allowed

March 30, 2016

PolyNovo US Collaboration Update

March 30, 2016

Polynovo to Commence First Human Trial

March 30, 2016

PolyNovo Human Trial Update

March 30, 2016

Polynovo Completes Pivotal Study on Burns

March 30, 2016

PolyNovo Clinical Trials Update

March 30, 2016

First PolyNovo Patent Allowed in US

March 30, 2016

Trading halt and request

March 30, 2016

Topical Negative Pressure Human Trial Completed

March 30, 2016

Positive Results from NovoSorb Human Clinical Trial

March 30, 2016

AOD9604 Positive in Osteoarthritis Animal Model

March 30, 2016

RAH Surgeons Receive Approval to use BTM

March 30, 2016

PolyNovo Receives CE Mark Approval for NovoPore

March 30, 2016

Financial Result Guidance

February 11, 2016

VAC Human Clinical Trial Update

February 10, 2016

US FDA approval

February 10, 2016

US BARDA Contract Application and BTM Trial Update

February 10, 2016

Update on US Partner Collaboration

February 10, 2016

Successful Proof of Concept for Synthetic Skin

February 10, 2016

Successful Clinical Trial Outcomes for NovoSorb BTM

February 10, 2016

Significant Organisational Structure Initiatives

February 10, 2016

Share Purchase Plan

February 10, 2016

Response to Media Speculation

February 10, 2016

Response to ASX Price and Volume Query

February 10, 2016

R and D Tax Refund Received

February 10, 2016

Preliminary Final Report

February 10, 2016

Polynovo Update

February 10, 2016

PolyNovos US FDA approval

February 10, 2016

PolyNovo Receives FDA 510k Clearance

February 10, 2016

PolyNovo Partners in the Field of Aesthetic Facial Surgery

February 10, 2016

PolyNovo Divests AOD9604

February 10, 2016

PolyNovo Concludes Recruitment for VAC Trial

February 10, 2016

PolyNovo completes acquisition of minorities

February 10, 2016

PolyNovo Commences Second Human Trial

February 10, 2016

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 36 decks. Every deck is listed under its year.